Beth E. Schilling

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson et al. · Toxicologic Pathology · 2006 · 92 citations · Full text

Molecular Pharmacology, Urological Research, Urology +14

Rodent Carcinogenicity Profile of the Antidiabetic Dual PPAR α and γ Agonist Muraglitazar

Sarah H. Tannehill‐Gregg, Thomas P. Sanderson, Daniel J. Minnema et al. · Toxicological Sciences · 2007 · 51 citations

Molecular Pharmacology, Urology, Oncology +15

Nonclinical Safety Evaluation of Muraglitazar, a Novel PPARα/γ Agonist

Crystal R. Waites, Mark A. Dominick, Thomas P. Sanderson et al. · Toxicological Sciences · 2007 · 41 citations · Full text

Toxicokinetics of 2′,3′-Didehydro-3′-Deoxythymidine, Stavudine (D4T)

Sanjeev Kaul, Kishor A. Dandekar, Beth E. Schilling et al. · Drug Metabolism and Disposition · 1999 · 34 citations

Strain-related Differences in Urine Composition of Male Rats of Potential Relevance to Urolithiasis

Sarah H. Tannehill‐Gregg, Mark A. Dominick, Amy J. Reisinger et al. · Toxicologic Pathology · 2009 · 24 citations